Loading...

Altimmune, Inc.

ALT•NASDAQ
Healthcare
Biotechnology
$2.82
$0.22(8.46%)
U.S. Market opens in 4h 17m

Altimmune, Inc. (ALT) Stock Overview

Explore Altimmune, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap248.9M
P/E Ratio-3.16
EPS (TTM)$-1.00
ROE-0.49%
Fundamental Analysis

AI Price Forecasts

1 Month$2.45
3 Months$2.42
1 Year Target$4.30

ALT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Altimmune, Inc. (ALT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.16 and a market capitalization of 248.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
8.46%
5-Day Change
-4.41%
1-Month Change
-9.62%
3-Month Change
-49.64%
6-Month Change
-30.37%
Year-to-Date (YTD) Change
-21.88%
1-Year Change
-45.45%
3-Year Change
-42.68%
5-Year Change
-79.81%
All-Time (Max) Change
-97.88%

Contact Information

https://altimmune.com
240 654 1450
910 Clopper Road, Gaithersburg, MD, 20878

Company Facts

59 Employees
IPO DateMay 26, 2017
CountryUS
Actively Trading

Frequently Asked Questions